Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: Role of its anti-adrenergic actions

Journal of Pineal Research

Volumn 45, Issue 4, 2008, Pages 449-458

  Genade, Sonia ^a   Genis, Amanda ^a   Ytrehus, Kirsti ^b   Huisamen, Barbara ^a   Lochner, Amanda ^a,c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NONE   (South Africa)

Author keywords

cAMP; Isoproterenol; Melatonin receptor; Nitric oxide; Perfused rat heart; Protein kinase C

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; BISINDOLYLMALEIMIDE; CYCLIC AMP; FORSKOLIN; GUANYLATE CYCLASE; ISOPRENALINE; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; PROTEIN KINASE C;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ADRENERGIC ANTAGONISTS; ANIMALS; CYCLIC AMP; FORSKOLIN; GUANYLATE CYCLASE; HEART; INDOLES; ISOPROTERENOL; MALE; MALEIMIDES; MELATONIN; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXADIAZOLES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROPRANOLOL; PROTEIN KINASE C; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, MELATONIN; TRYPTAMINES;

EID: 53749100860     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00615.x     Document Type: Article

References (55)

1. Reiter RJ, Tan D-X. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003 58 : 10 19.
2. Tengattini S, Reiter RJ, Tan D-X, Terron MP, Rodella LF, Rezzani R. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008 44 : 16 25.
3. Kaneko S, Okumura K, Numaguchi Y et al. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 2000 67 : 101 112.
4. Sahna E, Parlakpinar H, Turkoz Y et al. Protection of myocardium by melatonin against ischemia-reperfusion induced infarct size and oxidative changes. Physiol Res 2005 54 : 491 495.
5. Dobsak P, Siegelova J, Eicher JC et al. Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart. Pathophysiology 2003 9 : 179 187.
6. Lee YM, Chen HR, Hsiao G et al. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002 33 : 72 80.
7. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001 34 : 237 256.
8. Tan DX, Reiter RJ, Manchester LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002 2 : 181 198.
9. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003 34 : 1 10.
10. Tan DX, Chen LD, Poeggler B, Manchester LC, Reiter RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993 1 : 57 60.
11. Matuszak Z, Reszka K, Chignell CF. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic Biol Med 1997 23 : 347 372.
12. Zhang H, Squadrito GL, Pryor WA. The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. Biochem Biophys Res Commun 1998 251 : 83 87.
13. Turjanski AG, Leonik F, Roesnstein RF, Estrin DA, Doctorovich F. Scavenging of NO by melatonin. J Am Chem Soc 2000 122 : 10468 10469.
14. Lochner A, Genade S, Davids A, Ytrehus K, Moolman JA. Short- and long-term effects of melatonin on myocardial post-ischemic recovery. J Pineal Res 2006 40 : 56 63.
15. Rezzani R, Rodella LF, Bonomini F, Tengattini S, Banchi R, Reiter RJ. Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated. J Pineal Res 2006 41 : 288 295.
16. Iuvone PM, Gan J. Functional interaction of melatonin receptors and D1 dopamine receptors in cultured chick retinal neurones. J Neurosci 1995 15 : 2179 2185.
17. Iuvone PM, Gan J. Melatonin receptor mediated inhibition of cyclic AMP accumulation in chick retinal cell cultures. J Neurochem 1994 63 : 118 124.
18. Arvola L, Bertelsen E, Lochner A, Ytrehus K. Sustained anti-β-adrenergic effect of melatonin in guinea pig heart papillary muscle. Scand Cardiovasc J 2006 40 : 37 42.
19. Abete P, Bianco S, Calabrese C et al. Effects of melatonin in isolated rat papillary muscle. FEBS Lett 1997 412 : 79 85.
20. Acikel M, Buyukokuroglu ME, Aksoy H, Erdogan F, Erol MK. Protective effects of melatonin against myocardial injury induced by isoproterenol in rats. J Pineal Res 2003 35 : 75 79.
21. Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (cAMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol 1992 19 : 1622 1633.
22. Tan DX, Manchester LC, Reiter RJ et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 1998 25 : 184 191.
23. Lagneux C, Joyeux M, Demenge P et al. Protective effect of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 2000 66 : 503 509.
24. Bertuglia S, Reiter RJ. Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters. J Pineal Res 2007 42 : 55 63.
25. Massion PB, Pelat M, Belge C, Balligand J-L. Regulation of the mammalian heart function by nitric oxide. Mol Integr Physiol 2005 142 : 144 150.
26. Gustaffson AB, Brunton LL. Beta-adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1beta via message stabilization. Mol Pharmacol 2000 58 : 1470 1478.
27. Edoute Y, van der Merwe E, Sanan D, Kotze JCN, Syeinmann CM, Lochner A. Normothermic ischaemic arrest of the isolated working heart. Effect of time and reperfusion on myocardial ultrastructure, mitochondrial oxidative function and mechanical recovery. Circ Res 1993 58 : 663 678.
28. Kannengieser GJ, Opie LH, Van der Werff TJ. Impaired cardiac work and oxygen uptake after reperfusion of regionally ischaemic myocardium. J Mol Cell Cardiol 1979 11 : 197 207.
29. Marais E, Genade S, Salie R et al. The temporal relationship between p38MAPK and HSP27 activation in ischaemic and pharmacological preconditioning. Basic Res Cardiol 2005 100 : 35 47.
30. Marais E, Genade S, Salie R et al. Activation of p38MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38MAPK activity during sustained ischemia and reperfusion. J Mol Cell Cardiol 2001 33 : 769 778.
31. Tan D-X, Manchester LC, Ferran MP, Flores LD, Reiter RJ. One molecule, many derivatives: a never ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
32. Leon J, Acuna-Castrovielo D, Escames G, Tan D-X, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005 38 : 1 9.
33. Dubocovich ML. Melatonin receptors: role in sleep and circadian regulation. Sleep Med 2007 8 : 34 42.
34. Requintina PJ, Oxenkrug GF. Effect of luzindole and other melatonin receptor antagonists on iron and lipopolysaccharide-induced lipid peroxidation in vitro. Ann N Y Acad Sci 2007 1122 : 289 294.
35. Balligand J-L. Regulation of cardiac β-adrenergic response by nitric oxide. Cardiovasc Res 1999 43 : 607 620.
36. Reiter RJ, Tan DX, Sainz RM, Mayo JM, Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002 75 : 1299 1321.
37. Esposito E, Iacono A, Muid C et al. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 2008 44 : 78 87.
38. Slezak J, Buchwalow IB, Schulze W et al. Cellular control of nitric oxide synthase expression and activity in rat cardiomyocytes. Antioxid Redox Signal 2004 6 : 345 352.
39. Mahal HS, Sharma HS, Mukherjee T. Anti-oxidant properties of melatonin: a pulse radiolysis study. Free Radic Biol Med 1999 26 : 557 565.
40. Blanchard B, Pompon D, Ducroq C. Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res 2000 29 : 184 192.
41. Choi SI, Joo SS, Yoo YM. Melatonin prevents nitric oxide-induced apoptosis by increasing the interaction between 14-3-3 beta and β-Bad in Sk-N-MC cells. J Pineal Res 2008 44 : 95 100.
42. Bellon A, Ortiz-Lopez L, Ramirez-Rodriquez G, Anton-Tay F, Benitez-King G. Melatonin induces neuritogenesis at early stages in NIE-115 cells through actin rearrangements via activation of protein kinase C and Rho-associated kinase. J Pineal Res 2007 42 : 214 221.
43. Ramirez-Rodriquez G, Ortiz-Lopes L, Benitez-King G. Melatonin increases stress fibres and focal adhesions in MDCK cells. J Pineal Res 2007 42 : 180 190.
44. Soto-Vega E, Meza I, Ramirez-Rodriquez G, Benitez-King G. Melatonin stimulates calmodulin phosphorylation by protein kinase C. J Pineal Res 2004 37 : 98 106.
45. Perlini S, Khoury EP, Norton GR et al. Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. Circ Res 1998 83 : 761 771.
46. Arvola L, Hassef D, Melnikov AL, Helgesen KG, Ytrehus K. Adenosine induces prolonged anti-beta-adrenergic effects in guinea-pig papillary muscle. Acta Physiol Scand 2002 175 : 11 17.
47. Woolfson RG, Patel VC, Neild GH, Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 1995 91 : 1545 1551.
48. Depré C, Vanoverschelde JL, Goudemant JF, Mottet I, Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 1995 92 : 1911 1918.
49. Kobara M, Tatsumi T, Takeda M et al. The dual effects of nitric oxide inhibitors on ischemia-reperfusion injury in rat hearts. Basic Res Cardiol 2003 98 : 319 328.
50. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. Signal transduction in ischemic preconditioning. Cardiovasc Res 2001 52 : 181 198.
51. Lochner A, Genade S, Moolman JA. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 2003 98 : 337 346.
52. Hausenloy DJ, Yellon DM. Reperfusion salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007 12 : 217 234.
53. Castagnino HE, Lago N, Centrella JM et al. Cytoprotection by melatonin and growth hormone in early rat myocardial infarction as revealed by Feulgen DNA staining. Neuro Endocrinol Lett 2002 23 : 391 395.
54. Ha K-S, Kim K-M, Kwon Y-G et al. Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. FASEB J 2003 17 : 1036 1047.
55. Kawasaki K, Smith RS J r, Hsieh C-M et al. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol 2003 23 : 5726 5737.